top of page
Thomas Melzer
RiverVest
Series A, Series B
BioTech, Enterprise, Health & Hospital Services, Health IT, Pharmaceuticals
RiverVest is a leading venture capital firm building life science companies with a focus on biopharma and medical devices.
$100,000
-
$10,000,000
.png){kind=small}
bottom of page